Article: OCULAR COMPLICATIONS OF CHLOROQUINE THERAPY

Ocular complications of long-term chloroquine therapy were observed in 18 of 45 patients so treated. This therapy was used in patients with rheumatoid arthritis, lupus erythematosus, sarcoidosis, discoid lupus and other chronic "collagen disease". Thirteen patients had reversible corneal opacifications, and seven had irreversible retinal changes, with visual loss and visual field defects. Pathological evidence of chloroquine retinopathy was obtained in one patient. Physicians are therefore warned to use this drug only after careful consideration. If it is used, repeated ocular examinations should include assessment of visual acuity, visual fields on a tangent screen and fundus examination through a dilated pupil.

Citing Articles

Visual electrophysiology in the assessment of toxicity and deficiency states affecting the visual system.

ONeill E, Smith R Eye (Lond). 2021; 35(9):2344-2353.

PMID: 34290445 PMC: 8377028. DOI: 10.1038/s41433-021-01663-2.

Two years' experience of screening for hydroxychloroquine retinopathy.

Gobbett A, Kotagiri A, Bracewell C, Smith J Eye (Lond). 2020; 35(4):1171-1177.

PMID: 32636495 PMC: 8115138. DOI: 10.1038/s41433-020-1028-4.

Bone Remodeling and the Role of TRAF3 in Osteoclastic Bone Resorption.

Boyce B, Li J, Xing L, Yao Z Front Immunol. 2018; 9:2263.

PMID: 30323820 PMC: 6172306. DOI: 10.3389/fimmu.2018.02263.

Approaches for detecting lysosomal alkalinization and impaired degradation in fresh and cultured RPE cells: evidence for a role in retinal degenerations.

Guha S, Coffey E, Lu W, Lim J, Beckel J, Laties A Exp Eye Res. 2014; 126:68-76.

PMID: 25152362 PMC: 4143779. DOI: 10.1016/j.exer.2014.05.013.

Chloroquine retinopathy: is there a safe daily dose?.

Marks J Ann Rheum Dis. 1982; 41(1):52-8.

PMID: 7065730 PMC: 1000864. DOI: 10.1136/ard.41.1.52.

References

1.

HOBBS H, Sorsby A, FREEDMAN A . Retinopathy following chloroquine therapy. Lancet. 1959; 2(7101):478-80. DOI: 10.1016/s0140-6736(59)90604-x. View

2.

Reed H, Campbell A . Central scotomata following chloroquine therapy. Can Med Assoc J. 1962; 86:176-8. PMC: 1848697. View

3.

BERNSTEIN H, Ginsberg J . THE PATHOLOGY OF CHLOROQUINE RETINOPATHY. Arch Ophthalmol. 1964; 71:238-45. DOI: 10.1001/archopht.1964.00970010254019. View

4.

ELLSWORTH R, ZELLER R . Chloroquine (Aralen)-induced retinal damage. Arch Ophthalmol. 1961; 66:269-72. DOI: 10.1001/archopht.1961.00960010271019. View

5.

Penner R, Somers K . Bilateral macular degeneration associated with chloroquine therapy. Am J Ophthalmol. 1962; 54:381-5. DOI: 10.1016/0002-9394(62)93754-6. View

6.

Okun E, Gouras P, Bernstein H, VON SALLMANN L . Chloroquine retinopathy; a report of eight cases with ERG and dark-adaptation findings. Arch Ophthalmol. 1963; 69:59-71. DOI: 10.1001/archopht.1963.00960040065013. View

7.

HOBBS H, CALNAN C . The ocular complications of chloroquine therapy. Lancet. 1958; 1(7032):1207-9. DOI: 10.1016/s0140-6736(58)91911-1. View

8.

Arden G, Friedmann A, Kolb H . Anticipation of chloroquine retinopathy. Lancet. 1962; 1(7240):1164-5. DOI: 10.1016/s0140-6736(62)92200-6. View

9.

HOBBS H, Eadie S, Somerville F . OCULAR LESIONS AFTER TREATMENT WITH CHLOROQUINE. Br J Ophthalmol. 1961; 45(4):284-97. PMC: 510074. DOI: 10.1136/bjo.45.4.284. View

10.

KALSBEEK F . [Bilateral paralysis of the abducent nerve as cause of diplopia after the use of chloroquine]. Ned Tijdschr Geneeskd. 1960; 104:1414-6. View

11.

Hunt B, YENDT E . THE RESPONSE OF HYPERCALCEMIA IN SARCOIDOSIS TO CHLOROQUINE. Ann Intern Med. 1963; 59:554-64. DOI: 10.7326/0003-4819-59-4-554. View

12.

CALKINS L . Corneal epithelial changes occurring during chloroquine (aralen) therapy. AMA Arch Ophthalmol. 1958; 60(6):981-8. DOI: 10.1001/archopht.1958.00940081001001. View